The study found that bisphosphonates are effective in preventing fragility fractures. However, the benefit-to-risk ratio in the lowest risk patients may be debatable given the low absolute quality-adjusted life-year gains and the potential for adverse events.
http://ift.tt/2eny3AR
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου